Lam Francis F Y, Yeung John H K, Chan Kam M, Or Penelope M Y
Department of Pharmacology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Eur J Pharmacol. 2008 Jan 14;578(2-3):253-60. doi: 10.1016/j.ejphar.2007.09.040. Epub 2007 Oct 6.
In this study, we have investigated the actions of cryptotanshinone, an active, lipophilic component of the medicinal herb danshen (Salvia miltiorrhiza), on rat isolated coronary artery rings precontracted with 1 microM 5-hydroxytryptamine (5-HT) and its action compared to the ethanol-extractable fraction of the herb. Extraction of the ethanol-soluble fraction from danshen provided a yield of 1%. The amount of cryptotanshinone determined in this ethanol extract was 3.682%, and it was 6 times more potent than the extract in relaxing 5-HT-precontracted coronary artery rings; IC(50) values were 2.65+/-0.15 microg/ml and 15.82+/-1.07 microg/ml, respectively. Involvement of endothelium-dependant mechanisms in their dilator effects were investigated by pretreatment of the artery rings with a cyclooxygenase inhibitor flurbiprofen (10 microM), a nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 100 microM), a muscarinic receptor antagonist atropine (100 nM), and by mechanical removal of the endothelium; none of these procedures produced a significant change on their dilator actions. Involvement of endothelium-independent mechanisms was investigated in endothelium-denuded artery rings pretreated with a beta-adrenoceptor antagonist propranolol (100 nM), an adenylyl cyclase inhibitor 9-(tetrahydro-2-furanyl)-9H-purine-6-amine (SQ22536, 100 microM), a guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 microM), and a potassium channel inhibitor tetraethylammonium (TEA, 100 mM); these also produced no change on their dilator actions. The possible involvement of Ca(2+) channels was investigated in artery rings incubated with Ca(2+)-free buffer and primed with 1 microM 5-HT for 5 min prior to adding CaCl(2) to elicit contraction. The danshen ethanol extract (100 microg/ml) abolished the CaCl(2)-induced vasoconstriction, whereas, cryptotanshinone (30 microg/ml) produced 59% inhibition. These findings suggest their vasorelaxant effects are independent of pathways mediated by the endothelium, muscarinic receptors, beta-adrenoceptors, adenylyl cyclase, and guanylyl cyclase, whereas, inhibition of Ca(2+) influx in the vascular smooth muscle cells is important for their vasodilator actions. The high vasodilator potency and the quantity of salvianolic acid B contained in danshen ethanolic extract suggest it is an important constituent in this medicinal herb.
在本研究中,我们研究了隐丹参酮(一种药草丹参(Salvia miltiorrhiza)的活性亲脂性成分)对用1微摩尔5-羟色胺(5-HT)预收缩的大鼠离体冠状动脉环的作用,并将其作用与该草药的乙醇可提取物进行了比较。从丹参中提取乙醇可溶部分的得率为1%。在该乙醇提取物中测定的隐丹参酮含量为3.682%,其在舒张5-HT预收缩的冠状动脉环方面的效力比提取物高6倍;IC(50)值分别为2.65±0.15微克/毫升和15.82±1.07微克/毫升。通过用环氧化酶抑制剂氟比洛芬(10微摩尔)、一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME,100微摩尔)、毒蕈碱受体拮抗剂阿托品(100纳摩尔)预处理动脉环以及机械去除内皮来研究其舒张作用中内皮依赖性机制的参与情况;这些操作均未对其舒张作用产生显著影响。在用β-肾上腺素能受体拮抗剂普萘洛尔(100纳摩尔)、腺苷酸环化酶抑制剂9-(四氢-2-呋喃基)-9H-嘌呤-6-胺(SQ22536,100微摩尔)、鸟苷酸环化酶抑制剂1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ,10微摩尔)和钾通道抑制剂四乙铵(TEA,100毫摩尔)预处理的去内皮动脉环中研究内皮非依赖性机制的参与情况;这些操作也未对其舒张作用产生改变。在用无钙缓冲液孵育并在添加氯化钙以引发收缩之前用1微摩尔5-HT预刺激5分钟的动脉环中研究钙通道可能的参与情况。丹参乙醇提取物(100微克/毫升)消除了氯化钙诱导的血管收缩,而隐丹参酮(30微克/毫升)产生了59%的抑制作用。这些发现表明它们的血管舒张作用独立于由内皮、毒蕈碱受体、β-肾上腺素能受体、腺苷酸环化酶和鸟苷酸环化酶介导的途径,而抑制血管平滑肌细胞中的钙内流对其血管舒张作用很重要。丹参乙醇提取物中高血管舒张效力和丹酚酸B的含量表明它是这种药草中的一种重要成分。